Diversity in Renal Function Monitoring and Dose Modifications During Treatment for Childhood Cancer: A Call for Standardization

被引：5
作者：
Blufpand, Hester N. [1 ]
Hes, Nicole [1 ]
Bokenkamp, Arend [1 ]
van de Wetering, Marianne D. [2 ]
Kaspers, Gertjan J. L. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands
[2] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷 / 02期
关键词：
adverse effects; chemotherapy induced nephrotoxicity; childhood cancer; dose modifications in case of renal dysfunction; renal function; IFOSFAMIDE-INDUCED NEPHROTOXICITY; GLOMERULAR-FILTRATION-RATE; CYSTATIN-C; SERUM CREATININE; SARCOMA PATIENTS; KIDNEY-FUNCTION; RISK-FACTORS; CHILDREN; SURVIVORS; CARBOPLATIN;
D O I：
10.1002/pbc.24572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite changes in survival and drug tolerability, nephrotoxicity remains an important complication of chemotherapy. To provide cutting-edge care for children with cancer oncologist must be familiar with their nephrotoxic potential. Careful monitoring of renal function during treatment is therefore indicated. Well-defined guidelines for this are lacking. We reviewed current DCOG protocols and showed that monitoring of renal function during treatment varies widely between protocols. In some protocols recommended renal function measures are inappropriate given the chemotherapy prescribed. Advices on dose modifications in case of renal dysfunction also vary, even with comparable regimens. These differences are unwanted and call for standardization. Pediatr Blood Cancer 2014;61:337-344. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码：337 / 344
页数：8
相关论文
共 44 条
  • [41] Nephrotoxicity of cisplatin and carboplatin in sarcoma patients:: A report from the late effects surveillance system
    Stoehr, W.
    Paulides, M.
    Bielack, S.
    Juergens, H.
    Koscielniak, E.
    Rossi, R.
    Langer, T.
    Beck, J. D.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (02) : 140 - 147
  • [42] High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma - Incidence, treatment, and outcome
    Widemann, BC
    Balis, FM
    Kempf-Bielack, B
    Bielack, S
    Pratt, CB
    Ferrari, S
    Bacci, G
    Craft, AW
    Adamson, PC
    [J]. CANCER, 2004, 100 (10) : 2222 - 2232
  • [43] A Model-Based Estimate of Cumulative Excess Mortality in Survivors of Childhood Cancer
    Yeh, Jennifer M.
    Nekhlyudov, Larissa
    Goldie, Sue J.
    Mertens, Ann C.
    Diller, Lisa
    [J]. ANNALS OF INTERNAL MEDICINE, 2010, 152 (07) : 409 - W138
  • [44] Derivation and validation of cystatin C-based prediction equations for GFR in children
    Zappitelli, Michael
    Parvex, Paloma
    Joseph, Lawrence
    Paradis, Gilles
    Grey, Vijaylaxmi
    Lau, Susie
    Bell, Lorraine
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (02) : 221 - 230
12345